01.03.2013 Views

3. Umbruch 4.4..2005 - Online Pot

3. Umbruch 4.4..2005 - Online Pot

3. Umbruch 4.4..2005 - Online Pot

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

134 S.A. Varvel and A.H. Lichtman<br />

acetylcholine release in Delta9-tetrahydrocannabinol-induced impairment of spatial memory in<br />

the 8-arm radial maze. Life Sci 72: 397–407<br />

36 Braida D, Sala M (2000) Cannabinoid-induced working memory impairment is reversed by a second<br />

generation cholinesterase inhibitor in rats. Neuroreport 11: 2025–2029<br />

37 Molina-Holgado F, Gonzalez MI, Leret ML (1995) Effect of delta 9-tetrahydrocannabinol on<br />

short-term memory in the rat. Physiol Behav 57: 177–179<br />

38 Ferrari F, Ottani A, Vivoli R, Giuliani D (1999) Learning impairment produced in rats by the<br />

cannabinoid agonist HU 210 in a water-maze task. Pharmacol Biochem Behav 64: 555–561<br />

39 Varvel SA, Hamm RJ, Martin BR, Lichtman AH (2001) Differential effects of delta9-THC on spatial<br />

reference and working memory in mice. Psychopharmacology (Berl) 157: 142–150<br />

40 Varvel SA, Lichtman AH (2002) Evaluation of CB1 receptor knockout mice in the Morris water<br />

maze. J Pharmacol Exp Ther 301: 915–924<br />

41 Jentsch J, Andrusiak E, Tran A, Bowers M, Roth R (1997) ∆ 9 -Tetrahydrocannabinol increases prefrontal<br />

cortical catecholaminergic utilization and impairs spatial working memory in the rat:<br />

blockade of dopaminergic effects with HA966. Neuropsychopharmacology 16: 426–432<br />

42 Varvel SA, Anum E, Niyuhire F, Wise LE, Lichtman AH (2005) Delta(9)-THC-induced cognitive<br />

deficits in mice are reversed by the GABA(A) antagonist bicuculline. Psychopharmacology (Berl)<br />

178: 317–327<br />

43 Nava F, Carta G, Colombo G, Gessa GL (2001) Effects of chronic Delta(9)-tetrahydrocannabinol<br />

treatment on hippocampal extracellular acetylcholine concentration and alternation performance<br />

in the T-maze. Neuropharmacology 41: 392–399<br />

44 Castellano C, Cabib S, Palmisano A, Di Marzo V, Puglisi-Allegra S (1997) The effects of anandamide<br />

on memory consolidation in mice involve both D1 and D2 dopamine receptors. Behav<br />

Pharmacol 8: 707–712<br />

45 Murillo-Rodriguez E, Sanchez-Alavez M, Navarro L, Martinez-Gonzalez D, Drucker-Colin R,<br />

Prospero-Garcia O (1998) Anandamide modulates sleep and memory in rats. Brain Res 812:<br />

270–274<br />

46 Costanzi M, Battaglia M, Populin R, Cestari V, Castellano C (2003) Anandamide and memory in<br />

CD1 mice: effects of immobilization stress and of prior experience. Neurobiol Learn Memory 79:<br />

204–211<br />

47 Costanzi M, Battaglia M, Rossi-Arnaud C, Cestari V, Castellano C (2004) Effects of anandamide<br />

and morphine combinations on memory consolidation in cd1 mice: involvement of dopaminergic<br />

mechanisms. Neurobiol Learn Memory 81: 144–149<br />

48 Castellano C, Cabib S, Puglisi-Allegra S, Gasbarri A, Sulli A, Pacitti C, Introini-Collison IB,<br />

McGaugh JL (1999) Strain-dependent involvement of D1 and D2 dopamine receptors in muscarinic<br />

cholinergic influences on memory storage. Behav Brain Res 98: 17–26<br />

49 Reibaud M, Obinu MC, Ledent C, Parmentier M, Bohme GA, Imperato A (1999) Enhancement<br />

of memory in cannabinoid CB1 receptor knock-out mice. Eur J Pharmacol 379: R1–R2<br />

50 Bohme GA, Laville M, Ledent C, Parmentier M, Imperato A (2000) Enhanced long-term potentiation<br />

in mice lacking cannabinoid CB1 receptors. Neuroscience 95: 5–7<br />

51 Lichtman AH (2000) SR 141716A enhances spatial memory as assessed in a radial-arm maze task<br />

in rats. Eur J Pharmacol 404: 175–179<br />

52 Wolff MC, Leander JD (2003) SR141716A, a cannabinoid CB1 receptor antagonist, improves<br />

memory in a delayed radial maze task. Eur J Pharmacol 477: 213–217<br />

53 Mansbach RS, Rovetti CC, Winston EN, Lowe III JA (1996) Effects of the cannabinoid CB1<br />

receptor antagonist SR141716A on the behavior of pigeons and rats. Psychopharmacology 124:<br />

315–322<br />

54 Baskfield CY, Martin BR, Wiley JL (2004) Differential effects of delta9-tetrahydrocannabinol and<br />

methanandamide in CB1 knockout and wild-type mice. J Pharmacol Exp Ther 309: 86–91<br />

55 Zimmer A, Zimmer AM, Hohmann AG, Herkenham M, Bonner TI (1999) Increased mortality,<br />

hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc Natl Acad Sci<br />

USA 96: 5780–5785<br />

56 Martin M, Ledent C, Parmentier M, Maldonado R, Valverde O (2002) Involvement of CB1<br />

cannabinoid receptors in emotional behaviour. Psychopharmacology (Berl) 159: 379–387<br />

57 Westlake TM, Howlett AC, Bonner TI, Matsuda LA, Herkenham M (1994) Cannabinoid receptor<br />

binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and<br />

in situ hybridization histochemistry study of normal aged and Alzheimer’s brains. Neuroscience<br />

63: 637–652

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!